Načítá se...
P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB
Bevacizumab (BV) is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A) and is commonly used for treatment of recurrent glioblastoma (GBM). Wound healing problems are a well-established adverse event, which may be compounded by the concomitant use of corticosteroids. Here, we...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185639/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.280 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|